Power3 Medical Products, Inc. (OTC.BB:PWRM) released that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in October or November 2010. Completion of the merger is subject to customary closing conditions, including receipt by the parties of all necessary board and shareholder approvals and third party consents. There can be no assurance that these conditions will be met or that the merger will be completed.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

Alzheimer’s declines ultimately. Alzheimer’s is a progressing sickness, in which symptoms gradually worsen over a period of time. Continuing, memory loss is minor, but with late-stage Alzheimer’s, people will not be able to hold on a conversation and respond to their natural environment. Alzheimer’s disease is the 6th major cause of loss of life in the USA. Some people that have Alzheimer’s live life an average of eight years after their indications come to be noticeable to other people, but survival can range from 3 to 20 years, based on maturity and various health conditions.

Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which Power3 has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which Power3 is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

~~~~~~~~~~~~~~~~~~~~~~

Bioanalytical Systems Inc. (Nasdaq:BASI) has hired on Dec 11, 2010 veteran Lafayette-area journalist Sue Scott as its Marketing Communications Manager. The addition is part of the life science company’s effort to increase marketing and global business development efforts. Scott’s primary role with BASi will be to help develop news releases, presentations, and other promotional items and activities for the company. BASi is a leader in drug development services and research instrumentation.

Bioanalytical Systems, Inc. provides contract development services and research equipment to pharmaceutical, medical research, and biotechnology companies and institutions worldwide.

~~~~~~~~~~~~~~~~~~~~~~

Pacific Capital Bancorp (Nasdaq:PCBC) announced on Dec 13, 2010 the results of the semi-annual evaluation of the NASDAQ OMX ABA Community Bank Index, which will become effective prior to market open on Monday, December 20, 2010. These five securities will be added to the Index: Abington Bancorp, Inc. , First Interstate BancSystem, Inc., Pacific Capital Bancorp, Sterling Financial Corporation, and ViewPoint Financial Group, Inc.

Pacific Capital Bancorp operates as the holding company for Pacific Capital Bank, N.A., which provides a range of commercial and consumer banking services to households, professionals, and businesses primarily in the central coast of California.

~~~~~~~~~~~~~~~~~~~~~~

Inhibitex Inc. (Nasdaq:INHX) reported on Dec 13, 2010 top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.

Inhibitex, Inc., a biopharmaceutical company, focuses on the development of differentiated anti-infective products to prevent or treat serious infections, primarily shingles and chronic infections caused by hepatitis C virus (HCV).

~~~~~~~~~~~~~~~~~~~~~~

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

 

HIRU CORPORATION (PINKSHEETS:HIRU) subsidiary Jiangxi Shaungshi Pharmaceutical Co., Ltd launched the Jiangxi Shaungshi Biological Medicines Institute. Shuangshi AHP is currently researching several new veterinary drugs for development within the next two years. The company launched this new institute to strengthen and speed up the research and development processes. The Institute will allow the company a better focus and concentration of its talent in bio-tech development and research. Shaungshi AHP has elected Li Rui to be director of the institute.

Hiru Corporation, through its subsidiary, Jiangxi RongYu Pharmaceutical Group Co., Ltd., produces Chinese herbs for the naturopathic industry in China. It manufactures herbal supplements containing ginseng.

********************

Orofino Gold Corp. (PINKSHEETS:ORFG) is a China based gold producer with one producing gold mine in Colombia and an option on a strong portfolio of small producers and development/exploration assets in Colombia.

Orofino Gold was founded as a private company in 2009 by former executives and management with over 50 years of combined mining exploration, finance and development experience.

Orofino’s corporate objective is to continue to build shareholder value through the exploration and development of existing projects and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.

********************

Allos Therapeutics, Inc. (NASDAQ:ALTH) recently announced that five abstracts, describing FOLOTYN data across different types of blood cancers, were accepted in the program for this year’s 52nd American Society of Hematology Annual Meeting to be held December 4-7, 2010, in Orlando, Florida.

Allos Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing anti-cancer therapeutics.

********************

The Hallwood Group Incorporated (AMEX:HWG) recently reported results for the third quarter and nine months ended September 30, 2010. For the quarter, Hallwood reported net income of $407,000, or $0.27 per share, compared to net income of $4.1 million, or $2.67 per share, in 2009.

The Hallwood Group Incorporated, together with its subsidiaries, engages in the textile products business in the United States.

********************

Pacific Capital Bancorp (NASDAQ:PCBC), a community bank holding company, announced recently that it had returned to profitability after the completion of its recapitalization transactions during the third quarter of 2010. The Company reported net income of $5.0 million for the one month ended September 30, 2010. The one-month reporting is related to the Company after the closing of the $500 investment from a wholly-owned subsidiary of Ford Financial Fund, L.P. on August 31, 2010.

Pacific Capital Bancorp operates as the holding company for Pacific Capital Bank, N.A., which provides a range of commercial and consumer banking services to households, professionals, and businesses primarily in the central coast of California.

 

 

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Hiru Corporation (HIRU.PK) Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising .

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, reported that Power3 Medical Products delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3 Medical Products’ diagnostic test, and focused on Power3 Medical Products’ Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

Power3 Medical Products has filed several patent applications for its NuroPro® technology that are currently pending. Power3 Medical Products also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 Medical Products has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. PowPower3 Medical Productser3 intends to publish these latest findings as well.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical Products applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical Products has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which Power3 Medical Products has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which Power3 Medical Products is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

KBR (NYSE: KBR) disclosed recently that KBR has been awarded a contract to execute the topsides detailed design for TOTAL’s CLOV floating production, storage and offloading unit.

KBR is a global engineering, construction and services company supporting the energy, hydrocarbon, government services, minerals, civil infrastructure, power and industrial markets.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Pacific Capital Bancorp (Nasdaq: PCBC) and its wholly-owned subsidiary, Pacific Capital Bank, N.A., revealed recently the expiration and final results of Pacific Capital Bancorp’s previously revealed cash tender offers for any and all of its outstanding trust preferred securities and the Bank’s previously revealed cash tender offers for any and all of its outstanding subordinated debt securities.

Pacific Capital Bancorp is the parent company of Pacific Capital Bank, N.A., a nationally chartered bank that operates 48 branches.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

On September 16, 2010, the Board of Directors of Fauquier Bankshares, Inc. (Nasdaq: FBSS) declared the fourth quarter dividend of $0.12 per share for shareholders of record on December 17, 2010.

Fauquier Bankshares, Inc. operates as a holding company for The Fauquier Bank that provides consumer and commercial banking services to individuals, businesses, and industries in Virginia.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).

**************************************************************

 

UDS, Universal Technology Solutions, Inc. (DTSL.PK) works for food.

It also works for retail and other businesses. Wholly owned by Delivery Technology Solutions, the leader in providing comprehensive custom-developed catering/delivery solutions to industries throughout North America, UDS has mastered the five essentials of a business’ customer delivery solution.

UDS 5-Star Delivery Solutions include One Number/Online Ordering, Call Center Excellence, Point-of-Sale Integration, Site Delivery Coordination, and Marketing & Training Systems.

A business’ ideal delivery partner, UDS brings dedicated people together with advanced technology UDS has invested strategic time and capital into developing its 5-Star Delivery Solutions for chain businesses that are ready to expand their marketplace, win additional market-share and build their bottom line.

More about DTSL at: www.universaldelivery.com

EQ Labs, Inc. (EQLB.PK) announced today that it closed a deal with Terrible Herbst Corporation to place EQ Energy Drink in 108 Terrible Herbst convenience stores effective immediately. As a result of this closing, EQ Labs expects to receive a large commercial order for its energy drink to stock all 108 Terrible Herbst stores within the next 30 days.

Mo Owens, Chief Executive Officer of EQ Labs, stated, “This order is confirmation of the popularity of EQ. We have spent a lot of time and energy building our brand. This order provides the economic benefit of a large order. In addition, the advertising opportunity and the desired location of many of Terrible Herbst’s locations will place our product line in front of millions of potential customers. “

 

Owens added, “This deal would not be possible without the help of Mark Walters and Rio Valentino. Mark Walters, Director of Merchandising and Sales for Terrible Herbst is an expert in the sales and merchandising business. We are also consummating a relationship with a major distributor as a result of Mark’s extensive relationships. I also can’t forget Rio Valentino, our Vice President of Sales. Rio’s persistence and skills is one of the biggest reasons why are sales are beginning to accelerate and we hope to make many more announcements like this one over the near future. This is a very big moment for our company.”

More about EQLB at: www.drinkeq.com

 

Orofino Gold Corp. (PinkSheets:ORFG.PK) has gone where other mining companies have gone before, Colombia, and Colombia may just be the new California.

Mining is being promoted by the Colombian Government because mining has the potential to employ a lot of people.

Government efforts to expand mining in Colombia were needed to encourage private sector investment. The government set a policy of developing infrastructure (roads, electricity, and communications), providing technical assistance, and encouraging sound credit and legal policies to minimize problems with land titling.

Colombia has since made major improvements to its infrastructure. The deregulation process that began in the early 1990’s emphasized modernizing infrastructure in specific areas that are key to attaining global competitiveness.

Through joint ventures and the promotion of small mining companies, the mining sector can contribute more to national employment, income, and wealth.

Colombia is a free market economy with major commercial and investment ties to the United States. Transition from a highly regulated economy has been underway for more than 15 years with tariff reductions, financial deregulation, privatization of state-owned enterprises and adoption of a more liberal foreign exchange rate. These policies eased import restrictions and opened most sectors to foreign investment.

Foreign investors are welcomed as technology, management expertise, access to oversees markets, and finance, can be brought to the market
Colombia’s economy is heavily dependent upon its natural resources. Main exports include its well known coffee, petroleum and petroleum products, emeralds, fruits, flowers, iron and steel, textiles and apparel.

Colombia has not suffered any dramatic economic collapses. Prudent fiscal policies are maintained and economic reforms including tax; pension and budget reforms are pursued.

The sustained growth of the Colombian economy can be attributed to an increase in domestic security, the policies of keeping inflation low and maintaining a stable currency (the Colombian peso), petroleum price increases and an increase in exports to neighboring countries and the United States as a result of trade liberalization.

It appears that this is Colombia’s time, and Orofino may be in the right place at the right time.

More about ORFG at: www.orofinogold.com

Converted Organics Inc. (Nasdaq:COIN) today announced that CEO Edward J. Gildea was among eight “green” executives selected to present at the Agriculture 2.0 Global Investments Conference on September 14, 2010 in New York City. Mr. Gildea will discuss Converted Organics’ proprietary agricultural technology and TerraSphere’s vertical farming systems on the Agriculture 2.0 Investment Opportunities panel at 2:00 p.m. EDT. Converted Organics will also have an information display table at the event.

Agriculture 2.0 is produced by NewSeed Advisors, an integrated investment banking and management consulting practice that brings together sustainable agriculture entrepreneurs and investors. The September conference is NewSeed’s third in a series of events focused on the nuances of investing in sustainable agriculture on a global scale.

More about COIN at: www.convertedorganics.com

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

 

 

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (OTC:ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising services. Crown Equity Holdings Inc. (CRWE.OB) has received fifteen thousand dollars in cash from a third party (EEA, Inc ) for (7) days of advertising for EQ Labs, Inc. (EQLB.PK).Crown Equity Holdings Inc. (CRWE.OB) has received twenty-five thousand dollars in cash from a third party (Ceiba Network/PenStox) for (30) days of advertising for Delivery Technology Solutions, Inc. (DTSL.PK).

Dr Stock Pick HOT News & Alerts!

_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Wednesday March 17, 2010

DrStockPick.com Stock Report!

**************************************************************

CPF, Central Pacific Financial Corp.

Last Trade: $2.02 (+0.38 or +23.16) 2,957,586 shares traded so far

CPF operates as the bank holding company for Central Pacific Bank that provides commercial banking services in Hawaii.

________________________________________

BBX, BankAtlantic Bancorp Inc.

Last Trade: $2.44 (+0.32 or +15.09%) 3,418,869 shares traded so far

BBX operates as the bank holding company for BankAtlantic that provides retail and commercial banking products and services in Florida.

________________________________________

VHC, VirnetX Holding Corp.

Last Trade: $6.53 (+0.94 or +16.82%) 2,959,675 shares traded so far

VHC engages in developing and commercializing software and technology solutions for securing real-time communications over the Internet.

________________________________________

PDC, Pioneer Drilling Co.

Last Trade: $8.01 (+0.32 or +4.16%) 1,015,601 shares traded so far

PDC through its subsidiaries, provides contract land drilling services and production services to independent oil and gas exploration and production companies in the United States and Colombia.

________________________________________

MDCO, Medicines Co.

Last Trade: $9.93 (+1.67 or +20.16%) 4,016,676 shares traded so far

MDCO, a pharmaceutical company, provides medicines for the treatment of critical care patients worldwide. It markets Angiomax, an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty; and Cleviprex, a dihydropyridine calcium channel blocker, for the control of high blood pressure.

________________________________________

PCBC, Pacific Capital Bancorp

Last Trade: $1.97 (+0.31 or +18.67%) 4,693,764 shares traded so far

PCBC operates as the holding company for Pacific Capital Bank, N.A., which provides a range of commercial and consumer banking services to households, professionals, and businesses primarily in the central coast of California.

________________________________________

PLCM, Polycom, Inc.

Last Trade: $33.81 (+3.37 or +11.05%) 12,909,015 shares traded so far

PLCM provides communications solutions to enterprise, government, education, and healthcare customers to enable voice, video, and content communications. It operates in three segments: Video Communications Solutions, Voice Communications Solutions, and Services.

________________________________________

TNXI, Telanetix, Inc., TNXI.OB

Last Trade; $0.122 (+0.041 or +50.62%) 3,549,565 shares traded so far

TNXI operates as a communications solutions provider, offering voice services and video telepresence solutions to the business market.

________________________________________

IMDS, Imaging Diagnostic Systems Inc., IMDS.OB

Last Trade: $0.07 (+0.01 or 15.00%) 35,410,359 shares traded so far

IMDS, a development stage medical technology company, engages in commercializing medical imaging equipment worldwide. The company offers computed tomography laser mammography (CTLM) for detecting breast cancer. CTLM is an imaging modality offering the potential of molecular functional imaging, which could visualize the process of angiogenesis and might be used to distinguish between benign and malignant tissue. It is designed to be used in conjunction with mammography.

________________________________________

**************************************************************

**************************************************************

***********Advertisement***********

********************************

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) . Rule 17B requires disclosure of payment for investor relations.